(Q45722072)

English

Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients

scientific article published in February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients (English)

1 reference

Europe PubMed Central

15 December 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

15 December 2017

Jacintha O'Sullivan

10

1 reference

Europe PubMed Central

15 December 2017

11

1 reference

Europe PubMed Central

15 December 2017

author name string

Brendan Doyle

1

1 reference

Europe PubMed Central

15 December 2017

Suzanne Hagan

2

1 reference

Europe PubMed Central

15 December 2017

Lucy Scott

4

1 reference

Europe PubMed Central

15 December 2017

Sharon Harden

5

1 reference

Europe PubMed Central

15 December 2017

Jim Paul

6

1 reference

Europe PubMed Central

15 December 2017

Hugh Mulcahy

7

1 reference

Europe PubMed Central

15 December 2017

Graeme I Murray

8

1 reference

Europe PubMed Central

15 December 2017

Kieran Sheahan

9

1 reference

Europe PubMed Central

15 December 2017

publication date

1 February 2013

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

62

1 reference

Europe PubMed Central

15 December 2017

3

1 reference

Europe PubMed Central

15 December 2017

505-510

1 reference

Europe PubMed Central

15 December 2017

Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Converging patterns of colorectal cancer mortality in Europe

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Snail is a repressor of RKIP transcription in metastatic prostate cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Histopathology reporting in large bowel cancer

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Predictive poor prognostic factors in colonic carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12014

21 January 2018

Identifiers

10.1111/HIS.12014

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45722072&oldid=2077821245"